US Stock MarketDetailed Quotes

VERA Vera Therapeutics

Watchlist
  • 23.365
  • -0.635-2.65%
Trading Apr 30 13:04 ET
1.49BMarket Cap-8.50P/E (TTM)

Vera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
63.87%167.17M
80.98%48.91M
128.91%49.8M
69.97%37.34M
-0.47%31.11M
12.22%102.01M
-19.51%27.03M
-13.82%21.76M
45.91%21.97M
83.64%31.26M
Selling and administrative expenses
72.35%41M
149.35%15.57M
67.73%9.49M
39.95%8.03M
28.65%7.91M
8.57%23.79M
-9.59%6.24M
1.22%5.66M
16.06%5.74M
37.52%6.15M
-General and administrative expense
72.35%41M
149.35%15.57M
67.73%9.49M
39.95%8.03M
28.65%7.91M
8.57%23.79M
-9.59%6.24M
1.22%5.66M
16.06%5.74M
37.52%6.15M
Research and development costs
61.29%126.17M
60.44%33.35M
150.40%40.31M
80.59%29.31M
-7.60%23.2M
13.38%78.23M
-22.08%20.79M
-18.09%16.1M
60.51%16.23M
100.08%25.11M
Operating profit
-63.87%-167.17M
-80.98%-48.91M
-128.91%-49.8M
-69.97%-37.34M
0.47%-31.11M
-12.22%-102.01M
19.51%-27.03M
13.82%-21.76M
-45.91%-21.97M
-83.64%-31.26M
Net non-operating interest income expense
212.14%13.09M
430.09%4.79M
132.51%2.83M
140.91%3.19M
204.41%2.28M
453.17%4.19M
206.44%904K
189.29%1.22M
881.48%1.33M
914.13%749K
Non-operating interest income
159.61%20.71M
239.95%6.66M
120.62%4.76M
127.96%5.1M
157.92%4.19M
355.94%7.98M
119.24%1.96M
280.60%2.16M
751.33%2.24M
6,142.31%1.62M
Non-operating interest expense
101.43%7.63M
77.18%1.87M
105.30%1.94M
109.19%1.91M
118.08%1.91M
281.65%3.79M
76.29%1.06M
541.50%943K
614.06%914K
640.68%874K
Other net income (expense)
5.74%1.94M
48.51%698K
-21.28%344K
-8.28%443K
2.05%449K
67.89%1.83M
-44.58%470K
201.38%437K
600.00%483K
1,471.43%440K
Gain on sale of security
----
----
----
75.00%-7K
-300.00%-4K
----
----
----
89.06%-28K
99.65%-1K
Other non- operating income (expenses)
5.74%1.94M
48.51%698K
-21.28%344K
-11.94%450K
2.72%453K
-3.63%1.83M
-48.46%470K
25.94%437K
57.23%511K
40.00%441K
Income before tax
-58.50%-152.15M
-69.27%-43.42M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.65M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
Income tax
0.00%1K
0.00%1K
Net income
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
Net income continuous Operations
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
Minority interest income
Net income attributable to the parent company
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
18.54%-20.1M
-35.74%-20.16M
-76.00%-30.07M
Basic earnings per share
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
30.00%-0.56
32.84%-2.25
51.26%-0.58
50.55%-0.45
16.36%-0.46
-12.68%-0.8
Diluted earnings per share
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
30.00%-0.56
32.84%-2.25
51.26%-0.58
50.55%-0.45
16.36%-0.46
-12.68%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 63.87%167.17M80.98%48.91M128.91%49.8M69.97%37.34M-0.47%31.11M12.22%102.01M-19.51%27.03M-13.82%21.76M45.91%21.97M83.64%31.26M
Selling and administrative expenses 72.35%41M149.35%15.57M67.73%9.49M39.95%8.03M28.65%7.91M8.57%23.79M-9.59%6.24M1.22%5.66M16.06%5.74M37.52%6.15M
-General and administrative expense 72.35%41M149.35%15.57M67.73%9.49M39.95%8.03M28.65%7.91M8.57%23.79M-9.59%6.24M1.22%5.66M16.06%5.74M37.52%6.15M
Research and development costs 61.29%126.17M60.44%33.35M150.40%40.31M80.59%29.31M-7.60%23.2M13.38%78.23M-22.08%20.79M-18.09%16.1M60.51%16.23M100.08%25.11M
Operating profit -63.87%-167.17M-80.98%-48.91M-128.91%-49.8M-69.97%-37.34M0.47%-31.11M-12.22%-102.01M19.51%-27.03M13.82%-21.76M-45.91%-21.97M-83.64%-31.26M
Net non-operating interest income expense 212.14%13.09M430.09%4.79M132.51%2.83M140.91%3.19M204.41%2.28M453.17%4.19M206.44%904K189.29%1.22M881.48%1.33M914.13%749K
Non-operating interest income 159.61%20.71M239.95%6.66M120.62%4.76M127.96%5.1M157.92%4.19M355.94%7.98M119.24%1.96M280.60%2.16M751.33%2.24M6,142.31%1.62M
Non-operating interest expense 101.43%7.63M77.18%1.87M105.30%1.94M109.19%1.91M118.08%1.91M281.65%3.79M76.29%1.06M541.50%943K614.06%914K640.68%874K
Other net income (expense) 5.74%1.94M48.51%698K-21.28%344K-8.28%443K2.05%449K67.89%1.83M-44.58%470K201.38%437K600.00%483K1,471.43%440K
Gain on sale of security ------------75.00%-7K-300.00%-4K------------89.06%-28K99.65%-1K
Other non- operating income (expenses) 5.74%1.94M48.51%698K-21.28%344K-11.94%450K2.72%453K-3.63%1.83M-48.46%470K25.94%437K57.23%511K40.00%441K
Income before tax -58.50%-152.15M-69.27%-43.42M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.65M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M
Income tax 0.00%1K0.00%1K
Net income -58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M
Net income continuous Operations -58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M
Minority interest income
Net income attributable to the parent company -58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M18.54%-20.1M-35.74%-20.16M-76.00%-30.07M
Basic earnings per share -22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.6230.00%-0.5632.84%-2.2551.26%-0.5850.55%-0.4516.36%-0.46-12.68%-0.8
Diluted earnings per share -22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.6230.00%-0.5632.84%-2.2551.26%-0.5850.55%-0.4516.36%-0.46-12.68%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
CG MED EQUIP.
838810
+29.98%
BEOKA
870199
+29.96%
Shenzhen Bromake New Material
301387
+20.01%
4
Zhejiang Hongchang Electrical Technology
301008
+20.00%
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
+20.00%
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.